SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: DanZ who wrote (4520)8/16/2003 6:33:33 PM
From: StockDung   of 5582
 
Respones to Dans report, LOL
Stock Analyzer
Knowledge Gives Access to Powerful Choices

CLICK HERE to Publish Site Stockanalyzer for FREE!!

Calling All Girls! Free Cartoon Dolls!
E-Commerce $49.99/year! Click Here for Details

Graphics Gallery! Graphics Gallery and Search Animated GIFs Photos Icons Clip Art

Guestbook
--------------------------------------------------------------------------------
Order: Descending Ascending Record:
Record: 8
Date: Mon Apr 7, 2003 03:26:30 PM
Host: 66.134.55.50
Name:
Email Address:
Homepage URL:
Title of Homepage:
City:
State:
Country: United States
Site Rating: Excellent
Referred By: Web Surfing
Comments: I haven't seen anything this funny in years. The clown that did his "analysis" was SOOO far off the mark that only some snack bar attendant could have come up with this garbage. For that matter, even the author is trying to distance himself from his asinine claims.

Zicam sales NEVER materialized as Dan claimed they would, and as for the Gum business, not only were his numbers fantasy, the company couldn't make a profit selling the gum, so they sold their capacity. Dan now claims this is a good strategy. Can you get any dumber?

Record: 7
Date: Thu Mar 29, 2001 06:32:58 PM
Host: 24.4.254.105
Name: Steve Murphy
Email Address: smurf3320@aol.com
Homepage URL:
Title of Homepage:
City:
State: CO
Country: United States
Site Rating: Fair
Referred By: Web Surfing
Comments: It looks like analyst Zimmermann was valuing the gum side of the business at roughly $16 a share without the nic gum JV. WWY paid about $3/share. Did Wrigley get a great deal, or does the analyst need to sharpen his valuation skills?

Record: 6
Date: Tue Mar 6, 2001 12:57:37 AM
Host: 64.12.105.181
Name: Martin Cathcart-Jones
Email Address: cathcartjones@aol.com
Homepage URL:
Title of Homepage:
City:
State:
Country: United Kingdom
Site Rating: Excellent
Referred By: Web Surfing
Comments: To Dan Zimmerman - Just a quick note to thank you for your consistent and honest postings on GUMM that I keep reading on the Stocktalk bulletin board. I bought GUMM back in 1999 on the strength of an article in the London Times and as yet it has not taken off. I have decided not to sell but hold for the long term for if ZICAM really works and is protected by patent then it has to do very well one day. I don't check the Stocktalk board that often, but it is always reassuring to see your name in the list posting regularly. I know you are very keen on GUMM and possibly have viewed them as being better than they have performed, but I have always felt your postings were well reasoned and genuine. It does get a little tiring reading the same old same old from Bill Wexler and his chums, which is why I rarely check the bulletin board. Anyway, keep up the good work, hopefully GUMM will go nuclear one day.
By the way, next time you talk to Bill Hemelt try and get him to distribute Zicam in England and Europe. There is a nasty cold epidemic going round the country and I can't find Zicam anywhere. All the best. Martin C-J
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext